Exact Mass: 261.0961

Exact Mass Matches: 261.0961

Found 51 metabolites which its exact mass value is equals to given mass value 261.0961, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

gamma-Glutamylasparagine

(2S)-2-Amino-4-{[(1S)-1-carboxy-2-(C-hydroxycarbonimidoyl)ethyl]-C-hydroxycarbonimidoyl}butanoate

C9H15N3O6 (261.0961)


gamma-Glutamylasparagine is a dipeptide composed of gamma-glutamate and asparagine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. gamma-Glutamylasparagine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Asparaginylglutamic acid

(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]pentanedioic acid

C9H15N3O6 (261.0961)


Asparaginylglutamic acid is a dipeptide composed of asparagine and glutamic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutamylasparagine

(4S)-4-Amino-4-{[(1S)-1-carboxy-2-(C-hydroxycarbonimidoyl)ethyl]-C-hydroxycarbonimidoyl}butanoate

C9H15N3O6 (261.0961)


Glutamylasparagine is a dipeptide composed of glutamate and asparagine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamylasparagine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Aspartyl-Glutamine

2-[(2-Amino-3-carboxy-1-hydroxypropylidene)amino]-4-(C-hydroxycarbonimidoyl)butanoate

C9H15N3O6 (261.0961)


Aspartyl-Glutamine is a dipeptide composed of aspartate and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Glutaminylaspartic acid

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}butanedioate

C9H15N3O6 (261.0961)


Glutaminylaspartic acid is a dipeptide composed of glutamine and aspartic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Aspartyl-Gamma-glutamate

2-Amino-4-[(2-amino-3-carboxypropanoyl)-C-hydroxycarbonimidoyl]butanoate

C9H15N3O6 (261.0961)


Aspartyl-Gamma-glutamate is a dipeptide composed of aspartate and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   
   

H-GLY-GLU-GLY-OH

H-GLY-GLU-GLY-OH

C9H15N3O6 (261.0961)


   

SCHEMBL3681089

SCHEMBL3681089

C9H15N3O6 (261.0961)


   
   

2-[[2-[(2-aminoacetyl)amino]acetyl]amino]pentanedioic acid

2-[[2-[(2-aminoacetyl)amino]acetyl]amino]pentanedioic acid

C9H15N3O6 (261.0961)


   

Tris(2-hydroxyethyl) isocyanurate

1,3,5-Tris(2-hydroxyethyl)cyanuric acid

C9H15N3O6 (261.0961)


CONFIDENCE standard compound; INTERNAL_ID 582; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2494; ORIGINAL_PRECURSOR_SCAN_NO 2492 CONFIDENCE standard compound; INTERNAL_ID 582; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2502; ORIGINAL_PRECURSOR_SCAN_NO 2499 CONFIDENCE standard compound; INTERNAL_ID 582; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2512; ORIGINAL_PRECURSOR_SCAN_NO 2508 CONFIDENCE standard compound; INTERNAL_ID 582; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2513; ORIGINAL_PRECURSOR_SCAN_NO 2510 CONFIDENCE standard compound; INTERNAL_ID 582; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2505; ORIGINAL_PRECURSOR_SCAN_NO 2504

   
   
   
   
   
   
   
   
   
   
   
   
   

Asp-GLN

2-(2-amino-4-carbamoylbutanamido)butanedioic acid

C9H15N3O6 (261.0961)


A dipeptide formed from L-alpha-aspartyl and L-glutamine residues.

   

Asp-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]butanedioic acid

C9H15N3O6 (261.0961)


   

GLN-Asp

2-(2-amino-3-carboxypropanamido)-4-carbamoylbutanoic acid

C9H15N3O6 (261.0961)


   

GGlu-Asp

2-(2-amino-3-carboxypropanamido)-4-(C-hydroxycarbonimidoyl)butanoic acid

C9H15N3O6 (261.0961)


   

H-gamma-Glu-Gly-Gly-OH

H-gamma-Glu-Gly-Gly-OH

C9H15N3O6 (261.0961)


   

H-Gly-Gly-Glu-OH

H-Gly-Gly-Glu-OH

C9H15N3O6 (261.0961)


   

Aspartyl-Glutamine

Aspartyl-Glutamine

C9H15N3O6 (261.0961)


   

H-Gly-ala-asp-OH

H-Gly-ala-asp-OH

C9H15N3O6 (261.0961)


   

Ala-Asp-Gly

Ala-Asp-Gly

C9H15N3O6 (261.0961)


A tripeptide composed of L-alanine, L-aspartic acid, and glycine units joined in sequence by peptide linkages.

   

2-Deoxycytidine glycol

2-Deoxycytidine glycol

C9H15N3O6 (261.0961)


   

Glutamyl-glycyl-glycine

Glutamyl-glycyl-glycine

C9H15N3O6 (261.0961)


   
   
   
   
   

Asn-glu

Asn-glu

C9H15N3O6 (261.0961)


A dipeptide formed from L-asparagine and L-glutamic acid residues.

   
   

Aspartyl-Gamma-glutamate

Aspartyl-Gamma-glutamate

C9H15N3O6 (261.0961)


   

gamma-Glutamylasparagine

gamma-Glutamylasparagine

C9H15N3O6 (261.0961)


   

glutaminylaspartic acid

glutaminylaspartic acid

C9H15N3O6 (261.0961)


   

2-deoxy-5,6-dihydroxy-5,6-dihydrocytidine

2-deoxy-5,6-dihydroxy-5,6-dihydrocytidine

C9H15N3O6 (261.0961)


A nucleoside analogue that is the 5,6-dihydroxy-5,6-dihydro derivative of cytidine. It is a metabolite produced by the bacterium Mycoplasma genitalium.

   
   
   
   
   

(3s)-3-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-(carboxymethyl-c-hydroxycarbonimidoyl)propanoic acid

(3s)-3-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-(carboxymethyl-c-hydroxycarbonimidoyl)propanoic acid

C9H15N3O6 (261.0961)


   

(2s)-2-aminopropanoyl (2s)-2-amino-2-(1,5-dihydroxy-2-oxopyrrolidin-3-yl)acetate

(2s)-2-aminopropanoyl (2s)-2-amino-2-(1,5-dihydroxy-2-oxopyrrolidin-3-yl)acetate

C9H15N3O6 (261.0961)